SK

Swapan Kr Golder

Active Director Director DIN 10979170
DIN 10979170 First appointment Mar 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Swapan Kr Golder

Data last updated:

Swapan Kr Golder is a Director at Alivica Diagnostic Private Limited (since 2025).

DIN 10979170
Primary Designation Director
First Appointment 01 Mar 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Alivica Diagnostic Private Limited U86905WB2025PTC277051
Director01 Mar 20252025Active

Board colleagues of Swapan Kr Golder

NameDINCompanyDesignation
Sourav Golder10979171Alivica Diagnostic Private LimitedDirector

Directorship timeline

Open interactive timeline →
Alivica Diagnostic Private Limited
Premium access

Shareholding and investment profile for Swapan Kr Golder

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Swapan Kr Golder

Swapan Kr Golder currently holds 1 directorship: Alivica Diagnostic Private Limited (Director, since 01 Mar 2025).

Swapan Kr Golder was first appointed on 01 Mar 2025 as Director at Alivica Diagnostic Private Limited.

The current boards of Swapan Kr Golder's companies include Sourav Golder (Alivica Diagnostic Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available